Qtron Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,411
Closed -$438K 444
2022
Q1
$438K Hold
5,411
0.1% 258
2021
Q4
$556K Sell
5,411
-31
-0.6% -$2.98K 0.13% 224
2021
Q3
$476K Buy
+5,442
New +$493K 0.13% 223

Other funds holding SYNH

Qtron Investments's SYNH Position: Q2 2022 in Review

Qtron Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2022, closing a stake of 5,411 shares — an estimated $438K sold.

Qtron Investments first reported a position in SYNH in Q3 2021 and held it in 3 quarters. The position peaked at $556K in Q4 2021. 362 funds tracked by Wall St. Rank hold SYNH as of Q2 2022.

  • Qtron Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Qtron Investments sold 5,411 Syneos Health, Inc. Class A Common Stock shares in Q2 2022, an estimated $438K.
  • Qtron Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 3 quarters.
  • Qtron Investments's Syneos Health, Inc. Class A Common Stock position peaked at $556K in Q4 2021.
  • 362 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2022.

Based on Qtron Investments's 13F filing for Q2 2022, filed 10 Aug 2022.